About Skyline Ventures
Skyline Ventures is a Financial Services company based in Palo Alto (United States). US life sciences companies are invested in by Skyline Ventures. It operates on a B2B model. Its focus areas include Investment Industry, Venture Capital Funds, Independent Funds and Conventional VCs. Its legal entity in India is Skyline Ventures India Limited (L45200TG1988PLC009272).
Company details
Investments are directed by Skyline Ventures toward life sciences firms in the United States, with a focus on diagnostics, medical devices, and therapeutics. Portfolio holdings include AcelRx, Advion, Collegium Pharmaceutical, and DiscoveRx. Assets under management are valued at 800 million, and typical investment amounts range from 15 million to 35 million per company. Operations are based in Palo Alto.
- Headquarters Palo Alto, United States
- SectorsFinancial Services
- Website skylineventures.com
- Legal Name Skyline Ventures India Limited
- Date of Incorporation 17 Nov, 1988
- Jurisdiction Hyderabad, Telangana, India
- Indian entity net loss-₹2.4 Lakh
FY 2023 · 0% margin
- Indian entity EBITDA-₹1 Lakh
FY 2023 · 0% margin
Associated legal entities of Skyline Ventures
Skyline Ventures operates through Skyline Ventures India Limited, a listed company (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2023) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Skyline Ventures India Limited Listed CIN L45200TG1988PLC009272 | Active | 17 Nov 1988 | Hyderabad, Telangana | 5 | View details |
Board of directors of Skyline Ventures India Limited (Skyline Ventures)
Skyline Ventures India Limited is the primary company behind Skyline Ventures. The board of Skyline Ventures India Limited currently have 4 directors; the longest-serving is Nikshit Hemendra Shah, appointed in 2023. 29 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Nikshit Hemendra Shah DIN 07910462 | Director | 14 Aug 2023 | 3 yrs 2 mo | Skyline Ventures India Limited |
| Ajay Kumar Giri DIN 10254489 | Director | 14 Aug 2023 | 3 yrs 2 mo | Skyline Ventures India Limited |
| Anil DIN 09331597 | Additional Director | 03 Oct 2025 | 1 yr 1 mo | Skyline Ventures India Limited |
| Hannah Priyadarshini DIN 10103528 | Additional Director | 03 Oct 2025 | 1 yr 1 mo | Skyline Ventures India Limited |
Financials of Skyline Ventures
Figures of Skyline Ventures India Limited, the primary company behind Skyline Ventures, for FY 2023. Net loss was -₹2.4 Lakh (0% margin). EBITDA was -₹1 Lakh (0% margin). Revenue has grown at a compounded annual rate of -100% over five years.
- -₹2.4 LakhNet loss · 0% margin
- -₹1 LakhEBITDA · 0% margin
- ₹3.97 CrPaid-up capital
- -100%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Skyline Ventures India Limited are on its company page.
Detailed financial statements for Skyline Ventures
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Top companies in Venture Capital Funds
3 companies that operate in the same segment as Skyline Ventures (Venture Capital Funds) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Venture capital firm investing in early-stage tech startups | 1972 | Menlo Park, California, United States | ||||
Venture capital investments and support for entrepreneurs in technology and innovation sectors. | 1911 | Redwood City, California, United States | USD 691.23 K | |||
Accel is recognized as a leading venture capital firm. | 1983 | Palo Alto, California, United States |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Skyline Ventures
Complete news archive for Skyline Ventures
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Skyline Ventures
Skyline Ventures is headquartered in Palo Alto, United States. It is registered at Palo Alto, California, United States.
Investments are directed by Skyline Ventures toward life sciences firms in the United States, with a focus on diagnostics, medical devices, and therapeutics. Portfolio holdings include AcelRx, Advion, Collegium Pharmaceutical, and DiscoveRx. Assets under management are valued at 800 million, and typical investment amounts range from 15 million to 35 million per company. Operations are based in Palo Alto.
Skyline Ventures operates through Skyline Ventures India Limited.
The legal entities of Skyline Ventures currently have 5 directors, including Anil, Hannah Priyadarshini, Nikshit Hemendra Shah and others.